Literature DB >> 20093823

Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration.

Frank Gotch1, Nathan W Levin, Peter Kotanko.   

Abstract

Calcium mass balance (Ca(MB)) is determined by the difference between Ca absorbed between dialyses (Ca(Abs)) and the Ca removed during dialysis (J(d)Ca(2+)). A mathematical model to quantify (1) Ca(Abs) as a function of Ca intake (Ca(INT)) and the doses of vitamin D analogues, and (2) J(d)Ca(2+) as a function of Ca(2+) dialysance, the mean plasma Ca(2+) ((M)C(pi)Ca(2+)) minus dialysate Ca(2+) (C(di)Ca(2+)), ultrafiltration rate (Q(f)) and treatment time is developed in this paper. The model revealed a basic design flaw in clinical studies of Ca-based as opposed to non-Ca-based binders in that C(di)Ca(2+) must be reduced with the Ca-based binders in order to avoid a positive Ca(MB) relative to the non-Ca-based binders. The model was also used to analyze Ca(MB) in 320 Renal Research Institute hemodialysis patients and showed that all patients irrespective of type of binder were in positive Ca(MB) between dialyses (mean +/- SD 160 +/- 67 mg/day) with current doses of vitamin D analogues prescribed. Calculation of the optimal C(di)Ca(2+) for the 320 Renal Research Institute patients revealed that in virtually all instances, the C(di)Ca(2+) required for neutral Ca(MB), where Ca removal during dialysis was equal to Ca accumulation between dialyses, was less than 2.50 mEq/l and averaged about 2.00 mEq/l. This sharply contradicts the recent KDIGO (Kidney Disease: Improving Global Outcomes) Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease - Mineral and Bone Disorder, that suggests a C(di)Ca(2+) of 2.5-3.0 mEq/l. Review of the KDIGO work group discussions shows that this discrepancy stems from the unwarranted work group assumption that intradialytic Ca(MB) is zero. We strongly believe that this guideline for dialysate Ca(2+) is inappropriate and should be modified to more realistically reflect the needs of dialysis patients. Copyright (c) 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20093823     DOI: 10.1159/000245924

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  10 in total

Review 1.  Hyperphosphataemia: treatment options.

Authors:  Fabio Malberti
Journal:  Drugs       Date:  2013-05       Impact factor: 9.546

2.  Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients.

Authors:  Patrick H Pun; John R Horton; John P Middleton
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-31       Impact factor: 8.237

3.  Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial.

Authors:  Patrick H Pun; Safa Abdalla; Geoffrey A Block; Glenn M Chertow; Ricardo Correa-Rotter; Bastian Dehmel; Tilman B Drüeke; Jürgen Floege; William G Goodman; Charles A Herzog; Gerard M London; Kenneth W Mahaffey; Sharon M Moe; Patrick S Parfrey; David C Wheeler; John P Middleton
Journal:  Hemodial Int       Date:  2015-11-13       Impact factor: 1.812

4.  Calcium mass balances in bicarbonate hemodialysis.

Authors:  Carlo Basile
Journal:  Int J Nephrol       Date:  2011-04-26

5.  Effects of lowering dialysate calcium concentrations on arterial stiffness in patients undergoing hemodialysis.

Authors:  Jwa-Kyung Kim; Sung Jin Moon; Hyeong Cheon Park; Jae Sung Lee; Soung Rok Sim; Sung Chang Bae; Sung Kyu Ha
Journal:  Korean J Intern Med       Date:  2011-09-13       Impact factor: 2.884

6.  Effects of the Use of Non-Calcium Phosphate Binders in the Control and Outcome of Vascular Calcifications: A Review of Clinical Trials on CKD Patients.

Authors:  Piergiorgio Bolasco
Journal:  Int J Nephrol       Date:  2011-06-09

7.  On-site production of a dialysis bath from dry salts. Results of solute concentration control by routine clinical chemistry.

Authors:  Joachim Beige; Steffen Lutter; Peter Martus
Journal:  Clin Kidney J       Date:  2012-06

Review 8.  Optimizing haemodialysate composition.

Authors:  Francesco Locatelli; Vincenzo La Milia; Leano Violo; Lucia Del Vecchio; Salvatore Di Filippo
Journal:  Clin Kidney J       Date:  2015-08-08

9.  Analytical solution of multicompartment solute kinetics for hemodialysis.

Authors:  Przemysław Korohoda; Daniel Schneditz
Journal:  Comput Math Methods Med       Date:  2013-11-06       Impact factor: 2.238

10.  Quantification of Dialytic Removal and Extracellular Calcium Mass Balance during a Weekly Cycle of Hemodialysis.

Authors:  Jacek Waniewski; Malgorzata Debowska; Alicja Wojcik-Zaluska; Andrzej Ksiazek; Wojciech Zaluska
Journal:  PLoS One       Date:  2016-04-13       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.